As of Jan 17, 2025, Insulet Corporation Intrinsic Value is $121.1. This suggests it may be overvalued by 56.1% compared to its current price of around $275.8.
As of Jan 17, 2025, Insulet Corporation's Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $275.8, using a discount rate of 9.6% and terminal growth rate of 3.0%.
Insulet Corporation is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $121.1, compared to a market price of around $275.8. This suggests a potential overvaluation of 56.1%.